Efficacy and safety with >3 years of inotersen treatment for the polyneuropathy of hereditary transthyretin amyloidosis

被引：0

作者：

Coelho, Teresa ^{[1
]}

Whelan, Carol ^{[2
]}

Conceicao, Isabel ^{[3
,4
]}

Brannagan, Thomas ^{[5
]}

Wang, Annabel ^{[6
]}

Polydefkis, Michael ^{[7
]}

Dyck, Peter ^{[8
]}

Plante-Bordeneuve, Violaine ^{[9
]}

Berk, John ^{[10
]}

Merlini, Giampaolo ^{[11
]}

Obici, Laura ^{[11
]}

Drachman, Brian ^{[12
]}

Gorevic, Peter ^{[13
]}

Schmidt, Hartmut ^{[14
]}

Plana, Josep Maria Campistol ^{[15
]}

Gamez, Josep ^{[16
]}

Kristen, Arnt ^{[17
]}

Mazzeo, Anna ^{[18
]}

Narayana, Arvind ^{[19
]}

Olugemo, Kemi ^{[20
]}

Aquino, Peter ^{[21
]}

Benson, Merrill ^{[22
]}

Gertz, Morie ^{[23
]}

机构：

[1] Ctr Hosp Univ Porto, Dept Neurophysiol, Porto, Portugal

[2] Royal Free Hosp, Natl Amyloidosis Ctr, London, England

[3] CHULN, Hosp Santa Maria, Lisbon, Portugal

[4] Univ Lisbon, Dept Neurosci, Fac Med, Lisbon, Portugal

[5] Columbia Univ, Med Ctr, Peripheral Neuropathy Ctr, New York, NY USA

[6] Univ Calif Irvine, Dept Neurol, Orange, CA 92668 USA

[7] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA

[8] Mayo Clin, Peripheral Nerve Res Lab, Rochester, MN USA

[9] CHU Henri Mondor, Dept Neurol, Creteil, France

[10] Boston Univ, Amyloidosis Ctr, Boston, MA 02215 USA

[11] IRCCS Fdn Policlin San Matteo, Amyloidosis Ctr, Pavia, Italy

[12] Penn Presbyterian Med Ctr, Dept Cardiovasc Med, Philadelphia, PA USA

[13] Mt Sinai Med Ctr, Dept Rheumatol, New York, NY 10029 USA

[14] Muenster Univ Hosp, Dept Gastroenterol Hepatol Endocrinol Diabetol &, Munster, Germany

[15] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Hosp Clin, Barcelona, Spain

[16] Hosp Univ Vall dHebron, Dept Neurol, Barcelona, Spain

[17] Heidelberg Univ Hosp, Amyloidosis Ctr, Heidelberg, Germany

[18] Univ Messina, Dept Neurol, Messina, Italy

[19] Akcea Therapeut, Global Med Affairs, Boston, MA USA

[20] Akcea Therapeut, Clin Dev, Boston, MA USA

[21] Akcea Therapeut, Global Drug Safety & Pharmacovigilance, Boston, MA USA

[22] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA

[23] Mayo Clin, Bone Marrow Transplant Program, Rochester, MN USA

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷

关键词：

D O I：

10.1016/j.jns.2021.117867

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

117867

引用

页数：3

共 50 条

[1] Efficacy and Safety With >3 Years of Inotersen Treatment for the Polyneuropathy of Hereditary Transthyretin Amyloidosis
Coelho, M.
Whelan, C.
Conceicao, I.
Brannagan, T., III
Wang, A.
Polydefkis, M.
Dyck, P.
Plante-Bordeneuve, V.
Berk, J.
Merlini, G.
Obici, L.
Drachman, B.
Gorevic, P.
Schmidt, H.
Campistol Plana, J.
Gamez, J.
Kristen, A.
Mazzeo, A.
Narayana, A.
Olugemo, K.
Aquino, P.
Benson, M.
Gertz, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 71 - 71
[2] Efficacy and safety with >3 years of inotersen treatment for hereditary transthyretin amyloid polyneuropathy
Brannagan, Thomas, III
Wang, Annabel
Polydefkis, Michael
Dyck, Peter
Berk, John
Drachman, Brian
Gorevic, Peter
Coelho, Teresa
Whelan, Carol
Conceicao, Isabel
Plante-Bordeneuve, Violaine
Merlini, Giampaolo
Obici, Laura
Schmidt, Hartmut
Plana, Josep Maria Campistol
Gamez, Josep
Kristen, Arnt
Mazzeo, Anna
Gentile, Luca
Narayana, Arvind
Olugemo, Kemi
Aquino, Peter
Benson, Merrill
Gertz, Morie
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 383 - 384
[3] EFFICACY AND SAFETY WITH MORE THAN 3 YEARS OF INOTERSEN TREATMENT FOR THE POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS
Coelho, Teresa
Whelan, Carol
Conceicao, Isabel
Brannagan, Thomas H., III
Wang, Annabel K.
Polydefkis, Michael J.
Dyck, Peter J.
Plante-Bordeneuve, Violaine
Berk, John L.
Merlini, Giampaolo
Obici, Laura
Drachman, Brian
Gorevic, Peter
Schmidt, Hartmut
Plana, Josep Campistol
Gamez, Josep
Kristen, Arnt
Mazzeo, Anna
Gentile, Luca
Narayana, Arvind
Olugemo, Kemi
Aquino, Peter
Benson, Merill
Gertz, Morie
MUSCLE & NERVE, 2021, 64 : S66 - S66
[4] Safety and efficacy of inotersen in patients with hereditary transthyretin amyloidosis with polyneuropathy (NEURO-TTR)
Gertz, Morie
Wang, Annabel
Coelho, Teresa
Cruz, Marcia Waddington
Polydefkis, Michael
Dyck, Peter
Scheinberg, Morton
Plante-Bordeneuve, Violaine
Berk, John
Barroso, Fabio
Brannagan, Thomas
Khella, Sami
Conceicao, Isabel
Gorevic, Peter
Monia, Brett
Benson, Merrill
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 399 - 400
[5] Safety and Efficacy of Inotersen in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (NEURO-TTR)
Wang, Annabel K.
Coehlo, Teresa
Waddington-Cruz, Marcia
Polydefkis, Michael J.
Dyck, Peter J.
Scheinberg, Morton
Plante-Bordeneuve, Violaine
Berk, John
Barroso, Fabio
Adams, David
Brannagan, Thomas
Whelan, Carol
Merlini, Giampaolo
Drachman, Brian
Heitner, Stephen
Conceicao, Isabel
Schmidt, Hartmut
Vita, Giuseppe
Campistol, Josep Maria
Gamez, Josep
Gane, Edward
Gorevic, Peter
Oliveria, Acary Souza Bulle
Monia, Brett
Hughes, Steve G.
Kwoh, Jesse
McEvoy, Bradley W.
Baker, Brenda F.
Shenker, Andrew
Millns, Helen
Bergemann, Rito
Ackermann, Elizabeth J.
Gertz, Morie
Benson, Merrill D.
ANNALS OF NEUROLOGY, 2017, 82 : S108 - S109
[6] Safety and Efficacy of Inotersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (NEURO-TTR)
Gertz, Morie
Wang, Annabel K.
Coelho, Teresa
Cruz, Marcia Waddington
Polydefkis, Michael J.
Dyck, Peter J.
Scheinberg, Morton
Plante-Bordeneuve, Violaine
Berk, John
Barroso, Fabio
Adams, David
Brannagan, Thomas
Whelan, Carol
Merlini, Giampaolo
Drachman, Brian M.
Heitner, Stephen B.
Conceicao, Isabel
Schmidt, Harmut
Vita, Giuseppe
Campistol, Josep M.
Gamez, Josep
Gane, Edward
Gorevic, Peter
Oliveira, Acary Souza Bulle
Monia, Brett P.
Hughes, Steven G.
Kwoh, Jesse
McEvoy, Bradley W.
Baker, Brenda F.
Ackermann, Elizabeth J.
Benson, Merrill D.
NEUROLOGY, 2018, 90
[7] SAFETY AND EFFICACY OF INOTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY (NEURO-TTR)
Gertz, Morie
Wang, Annabel
Cruz, Marcia Waddington
Polydefkis, Michael
Dyck, Peter
Scheinberg, Morton
Berk, John
Barroso, Fabio
Brannagan, Thomas
Drachman, Brian
Heitner, Stephen
Gorevic, Peter
Monia, Brett
Benson, Merrill
MUSCLE & NERVE, 2018, 58 : S55 - S55
[8] Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
Gorevic, Peter
Franklin, Jaclyn
Chen, Jihong
Sajeev, Gautam
Wang, Jessie C. H.
Lin, Hollis
EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 121 - 129
[9] Efficacy of inotersen for neuropathic impairment scores in patients with hereditary transthyretin amyloidosis with polyneuropathy
Yarlas, Aaron
Lovley, Andrew
Kessler, Asia Sikora
Brown, Duncan
Vera-Llonch, Montserrat
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 344 - 344
[10] EFFICACY OF INOTERSEN FOR NEUROPATHIC IMPAIRMENT SCORES IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY
Yarlas, Aaron
Lovley, Andrew
Brown, Duncan
Llonch, Montserrat Vera
Karam, Chafic
Khella, Sami
MUSCLE & NERVE, 2021, 64 : S61 - S61

← 1 2 3 4 5 →

Efficacy and safety with &gt;3 years of inotersen treatment for the polyneuropathy of hereditary transthyretin amyloidosis

Efficacy and safety with >3 years of inotersen treatment for the polyneuropathy of hereditary transthyretin amyloidosis